New insider Mobeck Kenneth S. claimed ownership of 56,610 shares (SEC Form 3)
$EDAP
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 01/01/2026 |
3. Issuer Name and Ticker or Trading Symbol
EDAP TMS SA [ EDAP ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock(1) | 56,610 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Options | (2) | 12/15/2032 | Common Stock | 375,000 | $11.68(3) | D | |
| Stock Options | (4) | 01/18/2034 | Common Stock | 100,000 | $6.22(5) | D | |
| Stock Options | (6) | 06/20/2035 | Common Stock | 165,000 | $1.74(7) | D | |
| Explanation of Responses: |
| 1. Includes restricted stock units ("RSUs") granted pursuant to the 2025 RSU (Free Share) Plan of the issuer on June 20, 2025. Each RSU represents the right to receive one share of EDAP common stock, four-sixths of which will vest on the second anniversary of the date of grant and the remaining two-sixths will vest in two installments on December 20, 2027 and on June 20, 2028, respectively. |
| 2. The options, which were granted on December 15, 2022, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options. |
| 3. The option exercise price reflected was converted from 9.94 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750. |
| 4. The options, which were granted on January 18, 2024, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable or will become exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options. |
| 5. The option exercise price reflected was converted from 5.29 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750. |
| 6. One-sixth of the options become exercisable on December 20, 2025, which is the six-month anniversary of the date of grant, and with respect to the remaining five-sixths of the options, one-thirtieth become exercisable at the end of each month following the six-month anniversary of the date of grant. |
| 7. The option exercise price reflected was converted from 1.48 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750. |
| /s/ Blandine Confort, as Attorney-in-Fact | 01/13/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||